Valtrix Holdings
← Back to portfolio

Solverance Health Systems

Response required

Healthcare Technology · Boston, MA

May 28 – Aug 13, 2026

last 12 weeks of telemetry

Expansion Monitor1 escalation open below the escalation threshold

Solverance Health Systems is 16 points below its escalation threshold — strategic priority alignment is the strongest theme at 58 against a threshold of 74. 1 escalation is open (1 moderate), the oldest running 4 weeks. No board direction has been issued, so nothing is formally assigned against it.

58

Highest signal

of 74 threshold

1

Open escalations

1 moderate

82%

Participation

coverage sufficient

0

Board actions

none assigned

What needs attention

3 active themes

Strategic Priority Alignment

21 independent participants · 6 functions

Developing58 / 74Rising 8wView evidence →

Reported by 21 independent participants across 6 functions, persistent for 8 weeks and rising.Escalation open

Execution Bandwidth

19 independent participants · 6 functions

Developing51 / 74Rising 7wView evidence →

Reported by 19 independent participants across 6 functions, persistent for 7 weeks and rising.

Leadership Direction Clarity

14 independent participants · 6 functions

Weak Signal38 / 74FlatView evidence →

Reported by 14 independent participants across 6 functions, persistent for 5 weeks.

Escalations

1 open of 1

Strategic Priority Alignment at Solverance Health Systems: competing priorities not yet reconciled at the leadership level

Moderate
Why it matters
Persistent and approaching the escalation threshold — cheap to address now, expensive once it crosses.
What changed
Confidence rising across consecutive weeks; coverage widened to 4 functions. (4 weeks open)
Next step
Assign an owner to watch it, or wait one more week of telemetry before acting.
View escalation history
DevelopingModerateOpenStrategic priority alignmenttriggered Jul 16, 2026

Signal confidence for a strategic priority alignment theme at Solverance Health Systems stands at 58 against a program threshold of 74, reported independently by 21 participants across 4 functions. The pattern is consistent with a known exposure at this company — second product line behind roadmap by two quarters — which the investment thesis assumes stays contained. Signal will confirm over the coming weeks whether confidence continues to climb.

Beacon lifecycle

Building — recurring and gaining cross-functional coverage.

Emerging
Developing
Material
Urgent
Stabilizing
Resolved
  1. Opened as Emerging

    auto

    Escalation opened — theme first surfaced above the noise floor.

    Jun 25
  2. EmergingDeveloping

    auto

    Confidence rising across consecutive weeks; coverage widened to 4 functions.

    Jul 2

What Signal observed

Confidence for the strategic priority alignment theme reached 58 against a threshold of 74, sustained across 6 weeks with reporting from 4 distinct functions (Executive, Engineering, Sales, Customer Success).

Organizational radar

all 8 themes scored

0

Escalated

2

Developing

Execution Bandwidth, Strategic Priority Alignment

6

Quiet

View all eight themes

Organizational radar

Solverance Health Systems across the eight themes

Every company is scored on the same eight themes, shaded against this program's own escalation threshold — so a quiet row means quiet, not unmeasured.

Company
Direction
Bandwidth
Comms
Alignment
Capacity
Talent
Friction
External
38
51
15
58
6
3
15
2

Confidence = unique reporters of a theme ÷ active participants over the rolling 4-week window. A cell turns red once it crosses its company's escalation threshold.

Board response

1 open escalation at Solverance Health Systems with no board direction assigned. Nothing is formally owned, and no actions are being tracked against them.

Create board direction →

high growth · held since March 2023 · Boston, MA

Company context
Employees
310
Signal seats
45
15% enrolled
Revenue
$67M ARR
EBITDA margin
8–11%

Investment thesis

Care-coordination software with 94% gross retention; thesis is expanding from care management into utilisation review.

Known exposures

  • ·Second product line behind roadmap by two quarters
  • ·Sales leadership changed twice in eighteen months

Signal data is PE-exclusive. Portfolio company leadership has no visibility into submissions, themes, or confidence scores.

Beacon detects. Bearing interprets. You decide.